Early Fall in C-Reactive Protein (CRP) Level Predicts Response to Tocilizumab in Rapidly Progressing COVID-19: Experience in a Single-Arm Pakistani Center

Introduction There are conflicting studies regarding the efficacy of tocilizumab use in coronavirus disease 2019 (COVID-19) disease. There is a special need to identify the parameters that could predict its response in early COVID-19 disease. Objective To report our experience with tocilizumab and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Khurshid, Saba, Rehman, Neelum, Ahmed, Saad, Ahmad, Bilal, Khurshid, Mustafa, Muhammad, Anjum, Siddiqi, Fuad A, Nayab, Dure, Saleem, Hasan, Saleem, Zulqurnain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717466/
https://www.ncbi.nlm.nih.gov/pubmed/34987916
http://dx.doi.org/10.7759/cureus.20031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717466/
https://www.ncbi.nlm.nih.gov/pubmed/34987916
http://dx.doi.org/10.7759/cureus.20031

Ejemplares similares